Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20961593rdf:typepubmed:Citationlld:pubmed
pubmed-article:20961593lifeskim:mentionsumls-concept:C0042216lld:lifeskim
pubmed-article:20961593lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:20961593lifeskim:mentionsumls-concept:C0025252lld:lifeskim
pubmed-article:20961593lifeskim:mentionsumls-concept:C0019721lld:lifeskim
pubmed-article:20961593lifeskim:mentionsumls-concept:C0282580lld:lifeskim
pubmed-article:20961593lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:20961593pubmed:issue2lld:pubmed
pubmed-article:20961593pubmed:dateCreated2010-11-8lld:pubmed
pubmed-article:20961593pubmed:abstractTextThree decades after the eradication of smallpox, the threat of bioterrorism and outbreaks of emerging diseases such as monkeypox have renewed interest in the development of safe and effective next-generation poxvirus vaccines and biodefense research. Current smallpox vaccines contain live virus and are contraindicated for a large percentage of the population. Safer, yet still effective inactivated and subunit vaccines are needed, and epitope identification is an essential step in the development of these subunit vaccines. In this study we focused on 4 vaccinia membrane proteins known to be targeted by humoral responses in vaccinees. In spite of the narrow focus of the study we identified 36T cell epitopes, and provide additional support for the physical linkage between T and B epitopes. This information may prove useful in peptide and protein-based subunit vaccine development as well as in the study of CD4 responses to poxviruses.lld:pubmed
pubmed-article:20961593pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:languageenglld:pubmed
pubmed-article:20961593pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:citationSubsetIMlld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20961593pubmed:statusMEDLINElld:pubmed
pubmed-article:20961593pubmed:monthDeclld:pubmed
pubmed-article:20961593pubmed:issn1096-0341lld:pubmed
pubmed-article:20961593pubmed:authorpubmed-author:PolandGregory...lld:pubmed
pubmed-article:20961593pubmed:authorpubmed-author:KennedyRichar...lld:pubmed
pubmed-article:20961593pubmed:copyrightInfoCopyright © 2010 Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:20961593pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20961593pubmed:day20lld:pubmed
pubmed-article:20961593pubmed:volume408lld:pubmed
pubmed-article:20961593pubmed:ownerNLMlld:pubmed
pubmed-article:20961593pubmed:authorsCompleteYlld:pubmed
pubmed-article:20961593pubmed:pagination232-40lld:pubmed
pubmed-article:20961593pubmed:dateRevised2011-10-5lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:meshHeadingpubmed-meshheading:20961593...lld:pubmed
pubmed-article:20961593pubmed:year2010lld:pubmed
pubmed-article:20961593pubmed:articleTitleThe identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.lld:pubmed
pubmed-article:20961593pubmed:affiliationMayo Vaccine Research Group, Mayo Clinic, Rochester MN 55905, USA. Kennedy.rick@mayo.edulld:pubmed
pubmed-article:20961593pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20961593pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed